Perspective on roseroot (rhodiola rosea) studies

Planta Medica

Volumn 75, Issue 11, 2009, Pages 1187-1190

  Blomkvist, Josefin ^a   Taube, Adam ^a   Larhammar, Dan ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Adaptogen; Crassulaceae; Rhodiola rosea; Statistics

Indexed keywords

PLACEBO; RHODIOLA ROSEA EXTRACT;

CLINICAL TRIAL; DEPRESSION; FATIGUE; GENERALIZED ANXIETY DISORDER; HUMAN; MENTAL PERFORMANCE; PHYSICAL ACTIVITY; RHODIOLA; SHORT SURVEY; SINGLE DRUG DOSE;

CLINICAL TRIALS AS TOPIC; FATIGUE; HUMANS; PLANT EXTRACTS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; RHODIOLA;

CRASSULACEAE; RHODIOLA ROSEA;

EID: 70350783904     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0029-1185720     Document Type: Short Survey

References (15)

1. Spasov AA,Wikman G, Mandrikov VB, Mironova IA, Neumoin VV. A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated lowdose regimen. Phytomedicine 2000; 7: 85-89
2. Spasov AA, Mandrikov VB, Mironova IA. Effect of Rhodaxon preparation on the psychophysiological and physical adaptations of students to learning load. Eksp Klin Pharmacol 2000; 63: 76-78
3. Darbinyan V, Kteyan A, Panossian A, Gabriellian E,Wikman G,Wagner H. Rhodiola rosea in stress induced fatigue - a double blind cross-over study of a standardized extract SHR-5 with repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine 2000; 7: 365-371
4. Darbinyan V, Aslanyan G, Amroyan E, Gabrielyan E, Malmström C, Panossian A. Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression. Nord J Psychiatry 2007; 61: 343-348
5. Walsh T. Placebo response in studies of major depression: variable, substantial, and growing. JAMA 2002; 287: 1840-1847
6. Shevtsov VA, Zholus BI, Shervarly VI, Vol'skij VB, Korovin YP, KhristichMP, Roslyakova NA, Wikman G. A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine 2003; 10: 95-105
7. Fintelmann V, Gruenwald J. Efficacy and tolerability of Rhodiola rosea extract in adults with physical and cognitive deficiencies. Adv Ther 2007; 24: 929-939
8. Bystritsky A, Kerwin L, Feusner JD. A pilot study of Rhodiola rosea (Rhodax ®) for generalized anxiety disorder (GAD). J Altern Complement Med 2008; 14: 175-180
9. Olsson MG, von Schéele B, Panossian AG. A randomized, double-blind, placebo-controlled, parallel-group study of the standardised extract SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Med 2009; 75: 105-112
10. DeBock K, Eijnde BO, Ramaekers M, Hespel P. Acute Rhodiola rosea intake can improve endurance exercise performance. Int J Sport Nutr Exerc Metab 2004; 14: 298-307
11. Walker TB, Altobelli SA, Caprihan A, Robergs RA. Failure of Rhodiola rosea to alter skeletal muscle phosphate kinetics in trained men. Metabolism 2007; 56: 1111-1117
12. Colson SN, Wyatt FB, Johnston DL, Autrey LD, Fitzgerald YL, Earnest CP. Cordyceps sinensis- and Rhodiola rosea-based supplementation inmale cyclist and its effect on muscle tissue oxygen saturation. J Strength Res 2005; 19: 358-363
13. Earnest CP,Morss GM,Wyatt F, Jordan AN, Colson S, Church TS, Fitzgerald Y, Autery L, Jurca R, Lucia A. Effects of a commercial herbal-based formula on exercise performance in cyclists. Med Sci Sports Exerc 2004; 36: 504-509
14. Walker TB, Robergs RA. Does Rhodiola rosea possess ergogenic properties? Int J Sport Nutr Exerc Metab 2006; 16: 305-315
15. Roland PD, Amundstuen L. Roseroot, statements and documentation. Tidsskr Nor Lægeforen 2007; 127: 882-883